119 related articles for article (PubMed ID: 3444799)
1. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?
Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA
Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin receptor antibodies associated with post-operative relapse of thyrotoxicosis in a pregnancy complicated by neonatal thyrotoxicosis.
Wilson R; Fraser WD; Gray CE; Alroomi LG; Thomson JA
Scott Med J; 1990 Feb; 35(1):21-2. PubMed ID: 2315685
[TBL] [Abstract][Full Text] [Related]
3. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease.
Wilson R; McKillop JH; Henderson N; Pearson DW; Thomson JA
Clin Endocrinol (Oxf); 1986 Aug; 25(2):151-6. PubMed ID: 3491692
[TBL] [Abstract][Full Text] [Related]
4. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
5. Congenital thyrotoxicosis in premature infants.
Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
[TBL] [Abstract][Full Text] [Related]
6. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
7. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
[TBL] [Abstract][Full Text] [Related]
9. Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators.
Prakash R
Eur J Nucl Med; 1996 Feb; 23(2):118-22. PubMed ID: 8925844
[TBL] [Abstract][Full Text] [Related]
10. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
Peakman M; Hussain M; Cundy T; Vergani D
J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
[TBL] [Abstract][Full Text] [Related]
11. Estimation of serum TSH receptor autoantibody concentration and affinity.
Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
[TBL] [Abstract][Full Text] [Related]
12. Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.
Talbot JN; Duron F; Féron R; Aubert P; Milhaud G
J Endocrinol Invest; 1989 Oct; 12(9):589-95. PubMed ID: 2573625
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to the thyrotropin receptor.
Rees Smith B; McLachlan SM; Furmaniak J
Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease.
Wilson R; Fraser WD; McKillop JH; Thomson JA
Acta Endocrinol (Copenh); 1989 Nov; 121(5):666-70. PubMed ID: 2573989
[TBL] [Abstract][Full Text] [Related]
15. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.
Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA
Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
18. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
Wilson R; McKillop JH; Pearson DW; Cuthbert GF; Thomson JA
J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.
Sato K; Yamazaki K; Kanaji Y; Ohnishi S; Kasanuki H; Demura H
Thyroid; 1998 Dec; 8(12):1123-6. PubMed ID: 9920368
[TBL] [Abstract][Full Text] [Related]
20. Spin echo nuclear magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy.
Reglinski J; Smith WE; Wilson R; Buchanan LM; McKillop JH; Thomson JA
Clin Endocrinol (Oxf); 1992 Oct; 37(4):319-24. PubMed ID: 1362374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
